Martin, Ana Carolina Baptista Moreno; Tomasin, Rebeka; Luna-Dulcey, Liany; Graminha, Angélica Elen; Naves, Marina Araújo; Teles, Ramon Handerson Gomes; Silva, Vinicius Duval da; Silva, James Almada da; Vieira, Paulo Cezar 
; Annabi, Borhane; Cominetti, Márcia Regina
Source: Cellular Oncology. Unidade: FCFRP
Subjects: NEOPLASIAS MAMÁRIAS, TERAPIA COMBINADA, GENGIBRE, METÁSTASE NEOPLÁSICA, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTIN, Ana Carolina Baptista Moreno et al. [10]-Gingerol improves doxorubicin anticancer activity and decreases its side effects in triple negative breast cancer models. Cellular Oncology, v. 43, n. 5, p. 915-929, 2020Tradução . . Disponível em: https://doi.org/10.1007/s13402-020-00539-z. Acesso em: 12 jun. 2024.APA
Martin, A. C. B. M., Tomasin, R., Luna-Dulcey, L., Graminha, A. E., Naves, M. A., Teles, R. H. G., et al. (2020). [10]-Gingerol improves doxorubicin anticancer activity and decreases its side effects in triple negative breast cancer models. Cellular Oncology, 43( 5), 915-929. doi:10.1007/s13402-020-00539-zNLM
Martin ACBM, Tomasin R, Luna-Dulcey L, Graminha AE, Naves MA, Teles RHG, Silva VD da, Silva JA da, Vieira PC, Annabi B, Cominetti MR. [10]-Gingerol improves doxorubicin anticancer activity and decreases its side effects in triple negative breast cancer models [Internet]. Cellular Oncology. 2020 ; 43( 5): 915-929.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1007/s13402-020-00539-zVancouver
Martin ACBM, Tomasin R, Luna-Dulcey L, Graminha AE, Naves MA, Teles RHG, Silva VD da, Silva JA da, Vieira PC, Annabi B, Cominetti MR. [10]-Gingerol improves doxorubicin anticancer activity and decreases its side effects in triple negative breast cancer models [Internet]. Cellular Oncology. 2020 ; 43( 5): 915-929.[citado 2024 jun. 12 ] Available from: https://doi.org/10.1007/s13402-020-00539-z
